Skip to main content
Premium Trial:

Request an Annual Quote

Protein Pathways and Merck Collaborate

NEW YORK, April 4 - Protein Pathways said this week that it has started a research collaboration with Merck.


Wyeth will apply the company's pathway prediction technology to its drug discovery efforts.


Protein Pathways, based in Woodland Hills, Calif., predicts and integrates protein interaction networks from various types of data, including DNA sequence data, microarray gene expression data, literature abstracts, and protein interaction data, using proprietary computational methods.


It has constructed a human protein interaction map that includes more than 200,000 predicted interactions.


The company exclusively licenses technology developed by David Eisenberg at the University of California Los Angeles.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.